| Methods |
Pathology |
Ref |
| DNA genomic or mitocondrial techniques |
| DNA Microarrays |
Juvenile arthritis and spondyloarthropathy
Diabetic nephropathy
Lupus
Human stent-induced neointima |
[43-46] |
| array-CGH |
Endometriosis
Autism, epilepsy, and schizophrenia |
[47,48] |
| NGS |
Retinitispigmentosa
Familial cardiovasculardiseases
Dementia
Type 2 diabetes |
[49-52] |
| CNV |
Progression of Chronic Kidney Disease
Interstitial Lung Abnormalities
Valvular Calcification and Aortic Stenosis
Risk of Alzheimer's Disease
Rheumatoid arthritis
Elevated or reduced risk of type 2 diabetes |
[53-58] |
| DNA methylation |
Osteoarthritic disease
Alzheimer's disease
Dilated cardiomyopathy
Diabetes mellitus type 1 |
[59-62] |
| Comprehensive one-step analysis of the whole mitochondrial genome |
Mitochondrial dysfunction and complications associated with diabetes Disease progression in patients with single, large-scale mitochondrial DNA deletions |
[63,64] |
| Proteomics and metabolomics |
| 2D-electrophoresis |
Endometriosis
Amyotrophic lateral sclerosis (ALS)
Anderson-Fabry disease. |
[65-67] |
| MALDI/TOF, SELDI/TOF |
Systemic Sclerosis
COPD |
[68,69] |
| Nuclear magnetic resonance spectroscopy and mass spectrometry |
Metabolic syndrome and fatty liver disease Multiple sclerosis |
[70-71] |